112 related articles for article (PubMed ID: 3617996)
1. [Intra-arterial chemotherapy in advanced ovarian cancers. 2. Therapeutic results in relation to prognostic factors].
Lotze W; Richter P; Sarembe B
Zentralbl Gynakol; 1987; 109(9):578-85. PubMed ID: 3617996
[TBL] [Abstract][Full Text] [Related]
2. [Intra-arterial chemotherapy in advanced ovarian cancer. 1. Study conditions and prognostic factors].
Lotze W; Richter P; Sarembe B
Zentralbl Gynakol; 1987; 109(7):443-9. PubMed ID: 3303753
[TBL] [Abstract][Full Text] [Related]
3. [Intra-arterial chemotherapy in advanced ovarian cancer. 2. Technic, results, complications].
Lotze W; Richter P; Sarembe B
Zentralbl Gynakol; 1987; 109(8):532-9. PubMed ID: 3300103
[TBL] [Abstract][Full Text] [Related]
4. [Intra-arterial chemotherapy with methotrexate and 5-fluorouracil in extensive locoregional recurrences of cervix cancer].
Dziambor U; Sarembe B; Richter P; Lotze W
Zentralbl Gynakol; 1988; 110(18):1138-44. PubMed ID: 2465650
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of 63 advanced ovarian carcinomas].
Liu LY; Hong WJ; Hou YJ; Yao ZH; Wu AR; Li L
Zhonghua Zhong Liu Za Zhi; 1987 Sep; 9(5):375-8. PubMed ID: 3452529
[TBL] [Abstract][Full Text] [Related]
6. [Postoperative radio- and/or chemotherapy in ovarian stage III cancers. Results of a prospective randomized study].
Richter P; Sarembe B; Lotze W
Zentralbl Gynakol; 1985; 107(4):237-44. PubMed ID: 3885634
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors of ovarian cancer].
Ochiai K
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
[TBL] [Abstract][Full Text] [Related]
8. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
9. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
Gadducci A; Carnino F; Chiara S; Brunetti I; Tanganelli L; Romanini A; Bruzzone M; Conte PF
Gynecol Oncol; 2000 Feb; 76(2):157-62. PubMed ID: 10637064
[TBL] [Abstract][Full Text] [Related]
11. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of advanced ovarian cancer].
de Gramont A; Krulik M; Pigne A; Brissaud P; Sirinelli A; Hubert D; Zylberait D; Debray J
Sem Hop; 1984 Mar; 60(14):957-60. PubMed ID: 6326283
[TBL] [Abstract][Full Text] [Related]
14. [Combined modality for recurrent and disseminated ovarian cancer--CAPF combination chemotherapy and second-look operation].
Inagaki J; Ogawa M; Horikoshi N; Ezaki K; Inoue K; Aiba K; Komyo M; Miyamoto H; Ikeda K; Kubo H
Gan No Rinsho; 1983 Aug; 29(10):1291-5. PubMed ID: 6685195
[TBL] [Abstract][Full Text] [Related]
15. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy in the management of ovarian germ cell malignancies.
Schwartz PE
Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
[TBL] [Abstract][Full Text] [Related]
17. A review of 28 years of treating advanced ovarian cancer.
Krommer CF; Szalai JP
Anticancer Res; 1993; 13(3):817-25. PubMed ID: 8317918
[TBL] [Abstract][Full Text] [Related]
18. [Combined treatment and prognostic analysis of advanced epithelial ovarian carcinoma].
Huang X; Cai S; Fan J; Li Z
Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):291-3. PubMed ID: 12133404
[TBL] [Abstract][Full Text] [Related]
19. The impact of cisplat based chemotherapy on advanced ovarian cancer.
Prasad GR; Dalal AV; Tongaonkar HB; Chatterjee S; Kamat MR
J Postgrad Med; 1995; 41(4):95-8. PubMed ID: 10707728
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer].
Kosaka T; Ueshige N; Sugaya J; Nakano Y; Akiyama T; Tomita F; Saito H; Kita I; Takashima S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1288-91. PubMed ID: 9703810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
